Literature DB >> 24914241

Different associations of diabetes with β-cell dysfunction and insulin resistance among obese and nonobese Chinese women with prior gestational diabetes mellitus.

Weiqin Li1, Shuang Zhang2, Huikun Liu2, Leishen Wang2, Cuiping Zhang2, Junhong Leng2, Zhijie Yu3, Xilin Yang4, Huiguang Tian5, Gang Hu6.   

Abstract

OBJECTIVE: To examine the relative contributions of β-cell dysfunction and insulin resistance to postpartum diabetes risk among obese and nonobese women with prior gestational diabetes mellitus (GDM). RESEARCH DESIGN AND METHODS: We performed a cross-sectional survey 1-5 years after 1,263 women who had GDM gave birth. Polytomous logistic regression models were used to assess the associations of β-cell dysfunction (the lower quartile of HOMA-%β), insulin resistance (the upper quartile of HOMA-IR), decreased insulin sensitivity (the lower quartile of HOMA-%S), and different categories of BMI with prediabetes and diabetes risk.
RESULTS: β-Cell dysfunction, insulin resistance, and decreased insulin sensitivity all were significantly associated with hyperglycemic status across normal weight, overweight, and obese groups, and the patterns of insulin resistance and decreased insulin sensitivity were similar. BMI was inversely associated with β-cell dysfunction and positively associated with insulin resistance across normal glucose, prediabetes, and diabetes categories. Compared with women with normal glucose and weight, obese women with normal glucose had increased β-cell secretory function (odds ratio [OR] 0.09 [95% CI 0.02-0.37]) and insulin resistance (OR 17.4 [95% CI 9.47-31.9]). Normal weight diabetic women displayed the most β-cell dysfunction (OR 13.6 [95% CI 4.06-45.3]), whereas obese diabetic women displayed the highest insulin resistance (OR 45.8 [95% CI 18.5-113]).
CONCLUSIONS: For women with prior GDM, β-cell dysfunction had more pronounced contribution to postpartum diabetes among nonobese subjects, whereas insulin resistance contributed more to postpartum hyperglycemia among obese subjects.
© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Year:  2014        PMID: 24914241     DOI: 10.2337/dc14-0573

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  32 in total

1.  Racial/Ethnic Disparities in the Prevalence of Diabetes and Prediabetes by BMI: Patient Outcomes Research To Advance Learning (PORTAL) Multisite Cohort of Adults in the U.S.

Authors:  Yeyi Zhu; Margo A Sidell; David Arterburn; Matthew F Daley; Jay Desai; Stephanie L Fitzpatrick; Michael A Horberg; Corinna Koebnick; Emily McCormick; Caryn Oshiro; Deborah R Young; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2019-09-19       Impact factor: 19.112

2.  One-year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Programme: A randomized clinical trial.

Authors:  Huikun Liu; Leishen Wang; Shuang Zhang; Junhong Leng; Nan Li; Weiqin Li; Jing Wang; Huiguang Tian; Lu Qi; Xilin Yang; Zhijie Yu; Jaakko Tuomilehto; Gang Hu
Journal:  Diabetes Obes Metab       Date:  2018-02-15       Impact factor: 6.577

3.  Genetic Predisposition to Polycystic Ovary Syndrome, Postpartum Weight Reduction, and Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes.

Authors:  Tiange Wang; Junhong Leng; Nan Li; Aline Martins de Carvalho; Tao Huang; Yan Zheng; Weiqin Li; Huikun Liu; Leishen Wang; Gang Hu; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2015-10-02       Impact factor: 5.958

4.  The Circadian Rhythm-Related MTNR1B Genotype, Gestational Weight Gain, and Postpartum Glycemic Changes.

Authors:  Hoirun Nisa; Kevin H T Qi; Junhong Leng; Tao Zhou; Huikun Liu; Weiqin Li; Leishen Wang; Nan Li; Gang Hu; Lu Qi
Journal:  J Clin Endocrinol Metab       Date:  2018-06-01       Impact factor: 5.958

5.  Metabolic syndrome of weight change from pre-pregnancy to 1-5 years post-partum among Chinese women with prior gestational diabetes.

Authors:  W Li; H Liu; Y Qiao; F Lv; S Zhang; L Wang; J Leng; H Liu; L Qi; J Tuomilehto; G Hu
Journal:  Diabet Med       Date:  2015-05-28       Impact factor: 4.359

6.  Fasting and 2-hour plasma glucose, and HbA1c in pregnancy and the postpartum risk of diabetes among Chinese women with gestational diabetes.

Authors:  Huikun Liu; Shuang Zhang; Leishen Wang; Junhong Leng; Weiqin Li; Nan Li; Min Li; Yijuan Qiao; Huiguang Tian; Jaakko Tuomilehto; Xilin Yang; Zhijie Yu; Gang Hu
Journal:  Diabetes Res Clin Pract       Date:  2015-11-23       Impact factor: 5.602

7.  Maternal Gestational Diabetes Mellitus Modifies the Relationship Between Genetically Determined Body Mass Index During Pregnancy and Childhood Obesity.

Authors:  Zhaoxia Liang; Huikun Liu; Leishen Wang; Qiying Song; Dianjianyi Sun; Weiqin Li; Junhong Leng; Ru Gao; Gang Hu; Lu Qi
Journal:  Mayo Clin Proc       Date:  2020-09       Impact factor: 7.616

8.  Effects of obesity and a history of gestational diabetes on the risk of postpartum diabetes and hyperglycemia in Chinese women: Obesity, GDM and diabetes risk.

Authors:  Yuxin Fan; Weiqin Li; Huikun Liu; Leishen Wang; Shuang Zhang; Wei Li; Hongyan Liu; Junhong Leng; Yun Shen; Jaakko Tuomilehto; Zhijie Yu; Xilin Yang; Ming Liu; Gang Hu
Journal:  Diabetes Res Clin Pract       Date:  2019-08-28       Impact factor: 5.602

9.  Gestational hypertension and chronic hypertension on the risk of diabetes among gestational diabetes women.

Authors:  Xiaojing Yuan; Huikun Liu; Leishen Wang; Shuang Zhang; Cuiping Zhang; Junhong Leng; Ling Dong; Li Lv; Fengjun Lv; Huiguang Tian; Lu Qi; Jaakko Tuomilehto; Gang Hu
Journal:  J Diabetes Complications       Date:  2016-05-04       Impact factor: 2.852

10.  Nomograms for incident risk of post-partum type 2 diabetes in Chinese women with prior gestational diabetes mellitus.

Authors:  Weiqin Li; Junhong Leng; Huikun Liu; Shuang Zhang; Leishen Wang; Gang Hu; Jie Mi
Journal:  Clin Endocrinol (Oxf)       Date:  2018-10-23       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.